Protokinetix, Inc. is a research and development stage biotechnology company engaged in the scientific medical research of anti-aging glycoproteins. The company is headquartered in Dalton, Ohio. The company went IPO on 2002-01-07. Company is focused on scientific medical research of Anti-Freeze Glycoproteins (AFGPs) or anti-aging glycoproteins. The Company’s anti-aging glycopeptide is for ophthalmology, dermatology, transplant support and biomanufacturing. The commercial applications for AAGPs include various health care solutions. The firm has not developed a commercially viable product and has not generated any revenue.
PKTX stock price ended at $0.01 on 星期一, after rising 0.00%
On the latest trading day Jan 26, 2026, the stock price of PKTX rose by 0.00%, climbing from $0.01 to $0.01. During the session, the stock saw a volatility of 0.00%, with prices oscillating between a daily low of $0.01 and a high of $0.01. Notably, trading volume dropped by 85.3K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 279.0K shares were traded, equating to a market value of approximately $3.9M.